Biagio Ricciuti
机构：Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center · ORCID：0000-0002-0651-2678
发表论文 1113 篇 · 总被引 11290 次 · h-index 55
代表论文
- Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples (2026 · Nature Genetics · 被引 1)
- EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway (2026 · Cancer Discovery · 被引 1)
- Data from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)
- Supplementary Data1 from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco (2026)
- Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study (2026 · The Oncologist)
- Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial (2026 · The Lancet Oncology)